Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Flucytosine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 41Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo Pharma`s Generic Flucytosine Receives Approval in US
    Aurobindo Pharma`s Generic Flucytosine Receives Approval in US

    06 May 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213665

    FDA
    06 May 2020
    Share Share
    Aurobindo Pharma Gets USFDA Nod For Flucytosine Capsules
    Aurobindo Pharma Gets USFDA Nod For Flucytosine Capsules

    04 May 2020

    // MEDICALDIALOGUES

    https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-gets-usfda-nod-for-flucytosine-capsules-65470

    MEDICALDIALOGUES
    04 May 2020
    Share Share
    EMA recommendations on DPD testing prior to treatment with fluorouracil
    EMA recommendations on DPD testing prior to treatment with fluorouracil

    01 May 2020

    // EMA

    https://www.ema.europa.eu/en/news/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-flucytosine

    EMA
    01 May 2020
    Share Share
    Recipharm's Generic Flucytosine Receives Approval In US
    Recipharm's Generic Flucytosine Receives Approval In US

    21 Jun 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207536

    FDA
    21 Jun 2018
    Share Share
    MSF to WHO on Updated Guideline: Those Who Need These Medicines Cannot Afford Them
    MSF to WHO on Updated Guideline: Those Who Need These Medicines Cannot Afford Them

    07 Mar 2018

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2018/3/msf-to-who-on-updated-guideline-those-who-need-th

    Zachary Brennan RAPS
    07 Mar 2018
    Share Share
    Lupin eyes share of $48 mn market with anti-infection capsule launch in US
    Lupin eyes share of $48 mn market with anti-infection capsule launch in US

    05 Jan 2018

    // BUSINESS STANDARD

    http://www.business-standard.com/article/companies/lupin-eyes-share-of-48-mn-market-with-anti-infection-capsule-launch-in-us-118010500494_1.html

    BUSINESS STANDARD
    05 Jan 2018
    Share Share